Pulmonx (LUNG) Net Margin (2019 - 2025)

Pulmonx's (LUNG) quarterly Net Margin came in at 64.78% in Q3 2025, up 460.0% year-on-year from 11.57% in Q3 2024, and down 1.86% on a QoQ basis from 63.59% in Q2 2025.

Pulmonx (LUNG) Net Margin (2019 - 2025) Analysis & Trends

Pulmonx (LUNG) has 7 years of Net Margin data on file, last reported at 64.78% in Q3 2025.

  • On a quarterly basis, Net Margin rose 460.0% year-over-year to 64.78% in Q3 2025; TTM through Sep 2025 was 61.88%, a 1017.0% increase from a year earlier, with the FY2024 full-year figure at 67.3%, up 2129.0% from the prior year.
  • Net Margin for Q3 2025 stood at 64.78%, down from 63.59% in the prior quarter.
  • Over the last five years, Net Margin for LUNG reached as high as 55.44% in Q4 2024 and fell as low as 147.07% in Q1 2022.
  • Historically, Net Margin has averaged 88.75% across 5 years, with a median of 84.33% in 2023.
  • On a YoY basis, Net Margin climbed as much as 21910 bps in 2021 and fell as far as 5224 bps in 2021.
  • Year by year, Net Margin stood at 94.88% in 2021, then grew by 2 bps to 92.64% in 2022, then rose by 22 bps to 72.04% in 2023, then rose by 23 bps to 55.44% in 2024, then fell by 17 bps to 64.78% in 2025.
  • Per Business Quant data, the three most recent Net Margin figures were 64.78% in Q3 2025, 63.59% in Q2 2025, and 64.11% in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 9.65%
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 12.38%
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 12.84%
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 25.77%
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 16.74%
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 3.87%
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 8.01%
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Pulmonx 49.94 Mn -19.81 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2025 -64.78%
Jun 30, 2025 -63.59%
Mar 31, 2025 -64.11%
Dec 31, 2024 -55.44%
Sep 30, 2024 -69.38%
Jun 30, 2024 -73.82%
Mar 31, 2024 -73.00%
Dec 31, 2023 -72.04%
Sep 30, 2023 -84.33%
Jun 30, 2023 -93.96%
Mar 31, 2023 -109.12%
Dec 31, 2022 -92.64%
Sep 30, 2022 -104.96%
Jun 30, 2022 -104.95%
Mar 31, 2022 -147.07%
Dec 31, 2021 -94.88%
Sep 30, 2021 -76.44%
Jun 30, 2021 -106.38%
Mar 31, 2021 -135.35%
Dec 31, 2020 -94.58%